Below you will find news and press releases from industry, government, and academia regarding product developments and medical/scientific research news.
BioLife Solutions, Inc.(BioLife, a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, announced that its media products are embedded into the autologous cell therapy being developed by Pittsburgh-based Cook MyoSite, a subsidiary of the Cook Group, for treatment of female stress urinary incontinence. Read more.
Source: PharmaBiz.com, July 19, 2016
DENVER – Analytica on Wednesday announced that the U.S. Food and Drug Administration has approved the PeriCoach at-home pelvic floor trainer device and smartphone app as an over-the-counter treatment for mild, moderate and stress urinary incontinence and urge incontinence. Pelvic floor muscle exercise is recommended as first line non-pharmacologic treatment for the millions of women – estimated at one in three – who suffer from urinary incontinence. Read more.
Source: Drug Store News, July 13, 2016
SRS Medical Systems (Feeding Hills, MA) landed CE Mark approval for its Spanner temporary prostatic stent for men with bladder outlet obstructions. The Spanner temporary prostatic stent is an option over Foley and intermittent catheters, which are commonly used these days. Read more.
Source: Medgadget, June 29, 2016
Every day, Domtar improves the quality of peoples’ lives by providing dignity and choice through its Personal Care products. In line with its strategy and core capabilities, Domtar Corporation (NYSE: UFS) (TSX: UFS) has purchased the assets of Butterfly Health Inc. BUTTERFLY® body liners offer discreet, secure protection for accidental bowel leakage (ABL). “This product provides a unique solution to a problem that exists for roughly 1 out of 10 people. It represents a complementary addition to our portfolio of brands and technologies,” stated Mike Fagan, President of Domtar Personal Care. Read more.
Source: Business Wire, June 27, 2016
Axonics Modulation Technologies won European regulatory approval for its Sacral Neuromodulation System (SNM), a product designed to treat overactive bladder, urinary retention, and fecal incontinence. The device is rechargeable, and so can be used for longer periods than similar devices that have to be replaced with new batteries periodically. Read more.
Source: Medgadget, June 7, 2016
Hironic, a leading innovator of medical aesthetic laser and energy devices, announced that the world’s first HIFU urinary incontinence treatment clinical study using Ultra Vera™ was presented at the 18th Japanese Society of Female Pelvic Floor Medicine (JFPFM) held in Kitakyushu from June 11th to 12th. Read more.
Source: PR Rocket, June 25, 2016
Prostate cancer patients have seen their tumours destroyed with a revolutionary new laser treatment which has no side effects. Doctors in the US hailed the development as “exciting” because it could offer hope to millions of men diagnosed with the disease . Currently, prostate cancer is normally treated with surgery or radiotherapy which can result in erectile dysfunction and urinary incontinence. Read more.
Source: Mirror Online, June 10, 2016